Leading Women-Run Companies Shaping the Future of Business

The latest reports paint a nuanced picture: women are becoming a structural force in U.S. entrepreneurship, even as funding and systemic gaps persist. One of the clearest takeaways is scale. Women now own more than 40% of all U.S. businesses, employing roughly 12.6 million people and generating $2.8 trillion in revenues. Growth has also been faster than that of male-owned firms, with women-owned businesses expanding nearly twice as quickly between 2022 and 2025. This shift signals that female entrepreneurship is no longer niche—it is central to the U.S. small- and mid-sized business ecosystem, particularly in services, consumer, healthcare and increasingly tech-enabled sectors. The data suggests women are not just starting companies, but building durable, employment-generating enterprises, a key driver of long-term economic resilience.

Female founders are increasingly gaining traction in AI and next-generation technology markets, which have become the primary destinations for venture capital. This indicates a shift from traditional sectors into high-value, innovation-driven markets, positioning women at the center of future growth themes. According to PitchBook's 2025 Female Founders report, U.S. female-founded startups raised a record $73.6 billion in venture capital in 2025, representing 27.7% of total U.S. VC deal value, the highest share on record. Importantly, AI accounted for roughly two-thirds of all venture dollars invested in female-founded startups.

At the same time, capital is becoming more concentrated in fewer, larger deals—often in AI—suggesting that while top-tier female-led companies are scaling rapidly, broader participation remains uneven.

Despite strong progress, a significant funding gap continues to limit the full potential of female founders. All-female founding teams still receive only about 1–2% of total U.S. venture capital, even though evidence suggests they often deliver higher capital efficiency and competitive returns. This imbalance highlights a structural constraint within the venture ecosystem, where access to early-stage and growth funding remains uneven. As a result, many promising female-led startups may struggle to scale at the same pace as their peers, underscoring a sizable untapped opportunity for investors willing to address this gap.

Despite funding challenges, women-led companies continue to drive innovation and resilience, making them attractive investment opportunities. If you want to capitalize on it, our Women Run Companies Screen will help you spot high-potential stocks in this space.

Investors looking to capitalize on opportunities across diverse industries should consider Centene Corporation CNC in managed healthcare, Darling Ingredients Inc. DAR in sustainable ingredients and bio-nutrients, General Dynamics Corporation GD in aerospace and defense, FuelCell Energy, Inc. FCEL in clean energy and fuel cell technology, and The Chemours Company CC in specialty chemicals. These companies demonstrate strong leadership and strategic vision within their respective industries, positioning them for long-term growth and value creation.

Ready to uncover more transformative thematic investment ideas? Explore 39 cutting-edge investment themes with Zacks Thematic Investing Screens and discover your next big opportunity.

5 Women-Run Company Stocks to Buy Now

Centene: Sarah M. London has led Centene through one of the most significant strategic transformations in its history since becoming chief executive officer in 2022. Her leadership has focused on restoring profitability following elevated medical costs, strengthening underwriting discipline and improving execution across Medicaid, Medicare and Marketplace businesses. London has emphasized data-driven care management, pricing discipline and enterprise-wide cost optimization while reshaping the leadership structure to accelerate decision-making. These initiatives have positioned Centene to improve operating performance despite regulatory changes and shifting enrollment trends in government-sponsored healthcare programs.

The benefits of this strategy became increasingly evident in the company's second-quarter 2026 results. Total revenues increased 9.9% year over year to $53.6 billion, while adjusted earnings per share (EPS) reached $2.51, significantly exceeding expectations. The health benefits ratio improved to 89.6% from 93.0% a year earlier, reflecting better pricing, stronger medical cost management and improving profitability across key businesses. Centene also generated $3.6 billion in operating cash flow during the quarter and raised its full-year 2026 outlook, including revenue guidance of $193.5-$197.5 billion and adjusted EPS guidance to greater than $4.80, underscoring management's growing confidence in the earnings recovery.

London's most important contribution has been restoring investor confidence through disciplined execution rather than aggressive expansion. Although total at-risk membership declined to 25.9 million, reflecting industry-wide Medicaid and Marketplace normalization, Centene has prioritized higher-quality earnings, margin recovery and capital efficiency over enrollment growth. With stronger medical cost controls, improved balance-sheet flexibility and a renewed focus on operational excellence, London has repositioned Centene for more sustainable long-term earnings growth while navigating an increasingly complex regulatory environment. Currently, Centene sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Darling: Sandra Dudley has played an increasingly important role in Darling’s strategic transformation since joining the company in 2015 as vice president of Strategic Planning & Business Development. She subsequently served as senior vice president of Renewables and Strategy, and later as executive vice president of Renewables and U.S. Specialty Operations. In February 2025, she was appointed executive vice president, chief strategy officer, M&A and AI, expanding her responsibilities to include corporate strategy, mergers and acquisitions, and artificial intelligence initiatives. In this role, she helps shape Darling's long-term growth strategy by identifying value-accretive acquisitions, optimizing the business portfolio and leveraging AI to enhance operational efficiency.

Dudley's expanded role aligns with Darling's focus on disciplined capital allocation and operational optimization. Her strategic oversight supports the company's transition toward higher-value specialty ingredients while improving returns from its global rendering and renewable fuels businesses. In the second quarter of 2026, Darling reported net sales of $1.72 billion, combined adjusted EBITDA of $741.7 million and net income of $387.3 million, reflecting stronger execution across both its core ingredients business and the Diamond Green Diesel joint venture. The company also reduced net debt by $223 million during the quarter and received $280 million in cash distributions from Diamond Green Diesel, reinforcing its financial flexibility.

Dudley's influence extends beyond acquisitions to portfolio optimization and innovation. She has helped advance initiatives such as the Nextida collagen and gelatin platform while supporting strategic portfolio actions, including acquisitions and divestitures, to enhance long-term profitability. As Darling continues to deploy AI, optimize its global asset base and pursue disciplined growth opportunities, Dudley's strategic leadership is expected to strengthen competitive positioning, improve capital efficiency and support sustainable shareholder value creation. Currently, Darling carries a Zacks Rank #1.

General Dynamics: Phebe N. Novakovic has been the driving force behind General Dynamics' strategic evolution since becoming chairman and chief executive officer in 2013. Her leadership has centered on disciplined capital allocation, operational execution and investment in high-priority defense and aerospace platforms rather than pursuing large-scale acquisitions. This approach has enabled General Dynamics to strengthen its competitive position across nuclear submarines, combat vehicles, secure communications and Gulfstream business jets while maintaining consistent profitability and shareholder returns. Her focus on execution has also helped the company expand margins and generate robust cash flows across economic and defense spending cycles.

Novakovic's strategy is reflected in the company's latest operating performance. In the second quarter of 2026, General Dynamics reported revenues of $14.1 billion, up 8.1% year over year, while operating earnings increased 11.9% to $1.5 billion and EPS rose 13.4% to $4.24. Operating margin expanded 40 basis points to 10.4%, supported by growth across all four business segments. The company also generated $1.9 billion in operating cash flow and $1.6 billion in free cash flow, highlighting the effectiveness of Novakovic's emphasis on operational discipline and cash generation.

Novakovic has transformed General Dynamics into one of the defense industry's most financially resilient companies. Under her leadership, the company has built a record backlog of $136.5 billion, providing multi-year revenue visibility as global defense spending accelerates. Strong order inflows and continued investments to expand production capacity position General Dynamics to capitalize on sustained demand for naval platforms, combat systems and business aviation. Although supply-chain constraints and execution risks persist, Novakovic's conservative financial management and long-term strategic focus continue to support durable earnings growth and shareholder value creation. Currently, General Dynamics carries a Zacks Rank #2 (Buy).

FuelCell: Amanda J. Schreiber joined FuelCell as executive vice president, General Counsel and Corporate Secretary in January 2026, bringing more than two decades of experience in legal, commercial and governance leadership across the global power and infrastructure sectors. At FuelCell, she oversees the company's legal, compliance and corporate governance functions while serving as a strategic advisor to the executive leadership team and board of directors. Her prior experience at ContourGlobal, where she supported international project development, financings and mergers and acquisitions across more than 20 countries, strengthens FuelCell’s ability to execute complex commercial agreements and strategic partnerships in the rapidly evolving clean-energy market.

Schreiber's appointment comes at an important stage in FuelCell’s commercialization strategy. The company is expanding its manufacturing footprint, advancing its carbon capture collaboration with ExxonMobil and pursuing large-scale data center power opportunities, all of which require strong legal oversight and disciplined risk management. During the second quarter of fiscal 2026, FuelCell reported a sales pipeline of 4 gigawatts, up 267% sequentially, while maintaining a backlog of $1.14 billion. Although quarterly revenues declined 5% year over year to $35.6 million, the company strengthened liquidity, ending the quarter with $440.9 million in cash and restricted cash following successful equity raises.

While Schreiber is not directly responsible for operating performance, her contribution is strategically significant. Strong governance, contract execution and regulatory compliance are critical as FuelCell seeks to convert its expanding commercial pipeline into revenues and navigate project financings, technology collaborations and international deployments. Her expertise in enterprise risk management and complex infrastructure transactions should support management's long-term growth strategy, enhance execution discipline and strengthen investor confidence as the company works toward sustainable commercialization and improved financial performance. Currently, FuelCell carries a Zacks Rank #2.

Chemours: Denise M. Dignam has been instrumental in reshaping Chemours since joining the company in 2015, culminating in her appointment as president and chief executive officer in March 2024. Having previously led the Titanium Technologies and Advanced Performance Materials businesses, she brought deep operational expertise to the top role. Under her leadership, Chemours has focused on operational excellence, disciplined capital allocation and portfolio optimization while strengthening governance and restoring stakeholder confidence. Dignam has also emphasized innovation in next-generation refrigerants, advanced materials and titanium technologies, positioning the company to capitalize on long-term sustainability trends and evolving regulatory requirements.

Dignam's strategy is improving the quality of Chemours' operating performance despite a challenging demand environment. In the second quarter of 2026, the company reported net sales of $1.59 billion, broadly flat year over year as pricing gains across all three business segments largely offset lower volumes. Adjusted EBITDA was $247 million, near the high end of management's guidance, while adjusted EPS came in at 42 cents. More importantly, free cash flow increased 128% year over year to $114 million, free cash flow conversion improved to 46%, and net leverage declined to 4.4x, reflecting stronger cash generation and balance sheet improvement.

Dignam's leadership has also strengthened Chemours' long-term strategic positioning. She has accelerated cost-reduction initiatives, advanced the commercialization of Opteon low-global-warming-potential refrigerants and reinforced the company's balance sheet through prudent cash management. While macroeconomic uncertainty and cyclical demand remain challenges, her focus on operational execution, innovation and financial discipline has enhanced Chemours' earnings resilience and positioned the company to benefit from recovering industrial demand and increasing adoption of sustainable technologies. Currently, Chemours carries a Zacks Rank #2.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research